GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers

Kathleen Moore; Ana Oaknin; Isabelle Ray-Coquard; Robert Coleman; Thomas Herzog; David O'Malley; Stephanie Lheureux; Peter Rose; Robert Morris; David Starks; Grainger Lanneau; Fernanda Musa; Michael Nathenson; Amy Sauer; Darren Jolliffe; Marisa Rosenberg; Dennis Williams; Elliot Norry; Bradley Monk

doi:10.1016/j.ygyno.2024.07.417

Back

GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers

Journal article

Peer reviewed

GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers

Kathleen Moore, Ana Oaknin, Isabelle Ray-Coquard, Robert Coleman, Thomas Herzog, David O'Malley, Stephanie Lheureux, Peter Rose, Robert Morris, David Starks, …

Gynecologic oncology, Vol.190, pp.S281-S282

11/2024

DOI: https://doi.org/10.1016/j.ygyno.2024.07.417

Metrics

1 Record Views

Details

Title: GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers
Creators: Kathleen Moore - University of Oklahoma Health Sciences Center
Ana Oaknin - Hebron University
Isabelle Ray-Coquard - Centre Léon Bérard
Robert Coleman - Gynecologic Oncology Group
Thomas Herzog - University of Cincinnati
David O'Malley - The Ohio State University
Stephanie Lheureux - Princess Margaret Cancer Centre
Peter Rose - Cleveland Clinic
Robert Morris - Wayne State University
David Starks - Avera Health
Grainger Lanneau - East Carolina University
Fernanda Musa - Swedish Cancer Institute
Michael Nathenson - Adaptimmune
Amy Sauer - Adaptimmune
Darren Jolliffe - Adaptimmune
Marisa Rosenberg - Adaptimmune
Dennis Williams - Adaptimmune
Elliot Norry - Adaptimmune
Bradley Monk - University of Arizona
Publication Details: Gynecologic oncology, Vol.190, pp.S281-S282
Publisher: Elsevier Inc
Identifiers: 991006118537302656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers

Related links

Metrics

Details